InsidersTradesSigma
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Explore the complete record of transactions filed by Grunberg Gregory, Director. Insider active across 1 company, notably Kala Pharmaceuticals, Inc.. Aggregated, 2 reports have been published. History available since 17 June 2021. The latest transaction was filed on 17 June 2021 (Attribution). Regulator: SEC (Form 4). All data is openly available.
2 of 2 declarations
Gregory Grunberg is a Board Member at Kala Pharmaceuticals, Inc. He plays a key role in the governance and strategy of the company. His experience in the pharmaceutical sector helps guide the board's decisions.